Search

Gustavo A. Rosario Benitez

Examiner (ID: 599, Phone: (571)270-7888 , Office: P/2838 )

Most Active Art Unit
2838
Art Unit(s)
2838
Total Applications
811
Issued Applications
625
Pending Applications
91
Abandoned Applications
129

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 278118 [patent_doc_number] => 07557194 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-07 [patent_title] => 'Antibody materials for an IBD-associated polypeptide' [patent_app_type] => utility [patent_app_number] => 10/835914 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 14611 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/557/07557194.pdf [firstpage_image] =>[orig_patent_app_number] => 10835914 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/835914
Antibody materials for an IBD-associated polypeptide Apr 29, 2004 Issued
Array ( [id] => 7110586 [patent_doc_number] => 20050208041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)' [patent_app_type] => utility [patent_app_number] => 10/831459 [patent_app_country] => US [patent_app_date] => 2004-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20688 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208041.pdf [firstpage_image] =>[orig_patent_app_number] => 10831459 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/831459
Humanized antibodies to interferon alpha receptor-1 (IFNAR-1) Apr 22, 2004 Issued
Array ( [id] => 4517818 [patent_doc_number] => 07939076 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Methods for the therapy of Inflammatory Bowel Disease using a type-1 interferon antagonist' [patent_app_type] => utility [patent_app_number] => 10/831432 [patent_app_country] => US [patent_app_date] => 2004-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 47 [patent_no_of_words] => 13219 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939076.pdf [firstpage_image] =>[orig_patent_app_number] => 10831432 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/831432
Methods for the therapy of Inflammatory Bowel Disease using a type-1 interferon antagonist Apr 22, 2004 Issued
Array ( [id] => 7060574 [patent_doc_number] => 20050002934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Recombinant IL-9 antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/823253 [patent_app_country] => US [patent_app_date] => 2004-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 103138 [patent_no_of_claims] => 110 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20050002934.pdf [firstpage_image] =>[orig_patent_app_number] => 10823253 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/823253
Recombinant IL-9 antibodies Apr 11, 2004 Issued
Array ( [id] => 5857889 [patent_doc_number] => 20060228351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Method of inducing differentiation and proliferating regulatory t cell by anti-cd52 antibody and medicinal composition therefor' [patent_app_type] => utility [patent_app_number] => 10/551462 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13508 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20060228351.pdf [firstpage_image] =>[orig_patent_app_number] => 10551462 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/551462
Method of inducing differentiation and proliferating regulatory t cell by anti-cd52 antibody and medicinal composition therefor Mar 30, 2004 Abandoned
Array ( [id] => 6957895 [patent_doc_number] => 20050214265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Method for improving bone marrow engraftment' [patent_app_type] => utility [patent_app_number] => 10/808205 [patent_app_country] => US [patent_app_date] => 2004-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8535 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214265.pdf [firstpage_image] =>[orig_patent_app_number] => 10808205 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/808205
Method for improving bone marrow engraftment Mar 23, 2004 Abandoned
Array ( [id] => 5649021 [patent_doc_number] => 20060134756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Anti-IL-20 antibodies and binding partners and methods of using in inflammation' [patent_app_type] => utility [patent_app_number] => 10/807997 [patent_app_country] => US [patent_app_date] => 2004-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 81320 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134756.pdf [firstpage_image] =>[orig_patent_app_number] => 10807997 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/807997
Anti-IL-20 antibodies and binding partners and methods of using in inflammation Mar 23, 2004 Abandoned
Array ( [id] => 7285845 [patent_doc_number] => 20040146508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Use of cd25 binding molecules in steroid-resistant patients' [patent_app_type] => new [patent_app_number] => 10/474071 [patent_app_country] => US [patent_app_date] => 2004-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6928 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20040146508.pdf [firstpage_image] =>[orig_patent_app_number] => 10474071 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/474071
Use of cd25 binding molecules in steroid-resistant patients Mar 17, 2004 Abandoned
Array ( [id] => 6906168 [patent_doc_number] => 20050101563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Method and compositions for the treatment and prevention of pain and inflammation' [patent_app_type] => utility [patent_app_number] => 10/783160 [patent_app_country] => US [patent_app_date] => 2004-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42963 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101563.pdf [firstpage_image] =>[orig_patent_app_number] => 10783160 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/783160
Method and compositions for the treatment and prevention of pain and inflammation Feb 18, 2004 Abandoned
Array ( [id] => 7111130 [patent_doc_number] => 20050208585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Agonist antibodies' [patent_app_type] => utility [patent_app_number] => 10/778394 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 33187 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208585.pdf [firstpage_image] =>[orig_patent_app_number] => 10778394 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/778394
Agonist antibodies Feb 16, 2004 Abandoned
Array ( [id] => 7033578 [patent_doc_number] => 20050032087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Novel receptor-type phosphotyrosine phosphatase-alpha' [patent_app_type] => utility [patent_app_number] => 10/777144 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18597 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032087.pdf [firstpage_image] =>[orig_patent_app_number] => 10777144 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/777144
Novel receptor-type phosphotyrosine phosphatase-alpha Feb 12, 2004 Abandoned
Array ( [id] => 7038868 [patent_doc_number] => 20050158302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Methods for diagnosing and treating autoimmune disease' [patent_app_type] => utility [patent_app_number] => 10/775487 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 40299 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158302.pdf [firstpage_image] =>[orig_patent_app_number] => 10775487 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/775487
Methods for diagnosing and treating autoimmune disease Feb 9, 2004 Abandoned
Array ( [id] => 7371962 [patent_doc_number] => 20040219145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Compositions and methods to modulate immune and inflammatory responses' [patent_app_type] => new [patent_app_number] => 10/774708 [patent_app_country] => US [patent_app_date] => 2004-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6711 [patent_no_of_claims] => 122 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20040219145.pdf [firstpage_image] =>[orig_patent_app_number] => 10774708 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/774708
Methods for inducing apoptosis in ovarian carcinoma cells using an anti-regeneration and tolerance factor antibody Feb 8, 2004 Issued
Array ( [id] => 7372001 [patent_doc_number] => 20040219150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Uses of mammalian cytokine; related reagents' [patent_app_type] => new [patent_app_number] => 10/773083 [patent_app_country] => US [patent_app_date] => 2004-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19777 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20040219150.pdf [firstpage_image] =>[orig_patent_app_number] => 10773083 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/773083
Uses of mammalian cytokine; related reagents Feb 3, 2004 Abandoned
Array ( [id] => 7060569 [patent_doc_number] => 20050002929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Immune regulation based on the targeting of early activation molecules' [patent_app_type] => utility [patent_app_number] => 10/770639 [patent_app_country] => US [patent_app_date] => 2004-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 49207 [patent_no_of_claims] => 108 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20050002929.pdf [firstpage_image] =>[orig_patent_app_number] => 10770639 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/770639
Immune regulation based on the depletion of CD69+ cells Feb 1, 2004 Issued
Array ( [id] => 7308751 [patent_doc_number] => 20040142389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Antibodies to peptides that target GIT transport receptors and related methods' [patent_app_type] => new [patent_app_number] => 10/751699 [patent_app_country] => US [patent_app_date] => 2004-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2938 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142389.pdf [firstpage_image] =>[orig_patent_app_number] => 10751699 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/751699
Antibodies to peptides that target GIT transport receptors and related methods Jan 4, 2004 Abandoned
Array ( [id] => 7322370 [patent_doc_number] => 20040136994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Methods of using CR3 and CR4 ligands for inhibiting interleukin-12 to treat autoimmune disease' [patent_app_type] => new [patent_app_number] => 10/744659 [patent_app_country] => US [patent_app_date] => 2003-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10845 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20040136994.pdf [firstpage_image] =>[orig_patent_app_number] => 10744659 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/744659
Methods of using CR3 and CR4 ligands for inhibiting interleukin-12 to treat autoimmune disease Dec 22, 2003 Abandoned
Array ( [id] => 7206352 [patent_doc_number] => 20040087485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Educated nkt cells and their uses in the treatment of immune-related disorders' [patent_app_type] => new [patent_app_number] => 10/451811 [patent_app_country] => US [patent_app_date] => 2003-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21115 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087485.pdf [firstpage_image] =>[orig_patent_app_number] => 10451811 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/451811
Educated nkt cells and their uses in the treatment of immune-related disorders Dec 15, 2003 Abandoned
Array ( [id] => 7467882 [patent_doc_number] => 20040120935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Genetically modified yt cell line and use thereof' [patent_app_type] => new [patent_app_number] => 10/476007 [patent_app_country] => US [patent_app_date] => 2003-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1204 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20040120935.pdf [firstpage_image] =>[orig_patent_app_number] => 10476007 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/476007
Genetically modified yt cell line and use thereof Dec 8, 2003 Abandoned
Array ( [id] => 5284415 [patent_doc_number] => 20090098090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'VITRO IMMUNIZATION' [patent_app_type] => utility [patent_app_number] => 10/538393 [patent_app_country] => US [patent_app_date] => 2003-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10303 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20090098090.pdf [firstpage_image] =>[orig_patent_app_number] => 10538393 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/538393
VITRO IMMUNIZATION Dec 8, 2003 Abandoned
Menu